Genetically engineered virus kills cancer: study
- Published: 11 Feb 2013 at 01.44
- Online news: World
A genetically-engineered virus tested in 30 terminally-ill liver cancer patients significantly prolonged their lives, killing tumours and inhibiting the growth of new ones, scientists reported on Sunday.
A patient undergoes a scanner as radiology technicians look at the exam on a screen, on February 6, 2013, at a medical unit specialised in cancer treatment in France. A genetically-engineered virus tested in 30 terminally-ill liver cancer patients significantly prolonged their lives, killing tumours and inhibiting the growth of new ones, scientists reported on Sunday.
Sixteen patients given a high dose of the therapy survived for 14.1 months on average, compared to 6.7 months for the 14 who got the low dose.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.
